Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 10, 2021 07:00 ET | Source: InspireMD Inc.

InspireMD Announces Strong Second Quarter 2021 Financial Results

Revenue rebound, strong procedural recovery Management to host investor conference call today, August 10, 2021, at 8:30am ET TEL AVIV, Israel, Aug. 10, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc....
August 04, 2021 08:30 ET | Source: InspireMD Inc.

InspireMD to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021, and Provide Corporate Update

TEL AVIV, Israel, Aug. 04, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease...
July 23, 2021 08:30 ET | Source: InspireMD Inc.

InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS

TEL AVIV, Israel, July 23, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease...
June 02, 2021 08:04 ET | Source: InspireMD Inc.

InspireMD to Present at the LD Micro Virtual Invitational Conference on June 9, 2021

TEL AVIV, Israel, June 02, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq-CM: NSPR) developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by Carotid Artery...
May 27, 2021 08:00 ET | Source: InspireMD Inc.

InspireMD Announces Warrants Exchange Listing Transfer to Nasdaq

TEL AVIV, Israel, May 27, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of...
May 21, 2021 08:30 ET | Source: InspireMD Inc.

InspireMD Commences Trading on Nasdaq-CM

TEL AVIV, Israel, May 21, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq-CM: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by Carotid Artery...
May 14, 2021 06:00 ET | Source: InspireMD Inc.

InspireMD to Participate at the Investor Summit Conference and Present to Investors on May 17, 2021

TEL AVIV, Israel, May 14, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR) developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment...
May 12, 2021 06:00 ET | Source: InspireMD Inc.

InspireMD Announces Appointment of Katie Arnold to Board of Directors

TEL AVIV, Israel, May 12, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the...
May 11, 2021 06:00 ET | Source: InspireMD Inc.

InspireMD Announces First Quarter 2021 Financial Results

Company Completes Up-List to Nasdaq Capital Market, with Trading Becoming Effective May 21, 2021 Management to host investor conference call today, May 11, 2021, at 8:30am ET TEL AVIV, Israel,...
May 10, 2021 16:05 ET | Source: InspireMD Inc.

InspireMD Announces Stock Exchange Listing Transfer to Nasdaq

TEL AVIV, Israel, May 10, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the...

Next Page keyboard_arrow_right